第一医药
(600833)
| 流通市值：27.55亿 | | | 总市值：27.55亿 |
| 流通股本：2.23亿 | | | 总股本：2.23亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 333,182,890.03 | 322,594,697.71 | 368,915,925.25 | 370,767,879.28 |
| 交易性金融资产 | 10,029,663.26 | 1,029,600 | 34,700,000 | 19,700,000 |
| 应收票据及应收账款 | 200,473,405.48 | 188,588,158.67 | 172,162,204.84 | 157,935,555.44 |
| 应收账款 | 200,473,405.48 | 188,588,158.67 | 172,162,204.84 | 157,935,555.44 |
| 应收款项融资 | 3,569,524.26 | 1,290,212.76 | 5,449,354.7 | 3,505,101.69 |
| 预付款项 | 10,477,358.29 | 22,353,669.92 | 21,852,578.21 | 13,191,085.09 |
| 其他应收款合计 | 84,884,940.36 | 46,972,219.49 | 45,649,062.23 | 39,875,268.46 |
| 存货 | 366,140,064.62 | 354,935,802.63 | 406,629,703.58 | 424,789,975.34 |
| 一年内到期的非流动资产 | 21,595,000 | 98,041,277.78 | 129,837,812.77 | 107,925,689.49 |
| 其他流动资产 | 11,387,590.48 | 21,219,546.39 | 14,355,625.61 | 18,092,729.34 |
| 流动资产合计 | 1,041,740,436.78 | 1,057,025,185.35 | 1,199,552,267.19 | 1,155,783,284.13 |
| 非流动资产: | | | | |
| 债权投资 | 70,984,109.6 | 70,216,657.52 | 36,540,397.24 | 36,190,041.07 |
| 长期股权投资 | 2,173,242.52 | 2,173,242.52 | 1,006,778.53 | 1,006,778.53 |
| 其他权益工具投资 | 273,288,250.32 | 276,510,945.06 | 291,317,715.51 | 269,726,029.44 |
| 其他非流动金融资产 | 9,958,980.33 | 9,958,980.33 | - | - |
| 固定资产 | 80,607,215.08 | 81,579,269.46 | 81,834,874.65 | 83,867,352.97 |
| 在建工程 | 7,504,890.93 | 7,779,624.52 | 7,120,029.68 | 7,777,589.16 |
| 使用权资产 | 155,340,488.46 | 164,205,846.42 | 122,427,233.06 | 141,277,124.54 |
| 无形资产 | 35,861,477.85 | 36,455,983.88 | 37,172,480.54 | 37,747,035.97 |
| 长期待摊费用 | 23,746,859.36 | 24,569,953.09 | 24,451,520.47 | 19,937,693.94 |
| 递延所得税资产 | 23,999,200.22 | 26,756,807.05 | 36,037,141.01 | 32,153,694.46 |
| 其他非流动资产 | 265,814,784.92 | 264,091,817.67 | 193,233,555.13 | 223,108,272.78 |
| 非流动资产合计 | 949,279,499.59 | 964,299,127.52 | 831,141,725.82 | 852,791,612.86 |
| 资产总计 | 1,991,019,936.37 | 2,021,324,312.87 | 2,030,693,993.01 | 2,008,574,896.99 |
| 流动负债: | | | | |
| 短期借款 | 0 | 49,898,402.77 | 99,613,263.89 | 49,702,083.33 |
| 应付票据及应付账款 | 470,026,167.84 | 454,098,618.37 | 439,847,223.24 | 462,324,244.11 |
| 其中：应付票据 | 56,269,246.06 | 87,528,416.48 | 60,422,883.43 | 56,366,272.05 |
| 应付账款 | 413,756,921.78 | 366,570,201.89 | 379,424,339.81 | 405,957,972.06 |
| 预收款项 | 485,399.57 | 595,883.87 | 580,605.13 | 458,593.01 |
| 合同负债 | 8,923,698.29 | 2,958,877.17 | 10,701,902.56 | 4,969,566.59 |
| 应付职工薪酬 | 1,929,749.89 | 18,303,155.26 | 6,546,396.14 | 3,137,596.12 |
| 应交税费 | 2,395,155.15 | 7,235,981.93 | 18,897,456.6 | 6,603,529.82 |
| 其他应付款合计 | 65,904,439.74 | 69,096,300.95 | 69,023,181.99 | 139,838,266.7 |
| 应付股利 | 2,215,636.37 | 2,215,636.37 | 2,215,636.37 | 51,290,859.93 |
| 一年内到期的非流动负债 | 64,339,064.52 | 63,948,878.88 | 57,412,585.97 | 60,780,521.55 |
| 其他流动负债 | 1,220,299.93 | 356,351.13 | 677,183.92 | 646,043.67 |
| 流动负债合计 | 615,223,974.93 | 666,492,450.33 | 703,299,799.44 | 728,460,444.9 |
| 非流动负债: | | | | |
| 租赁负债 | 108,951,835.05 | 107,824,485.9 | 78,668,027.52 | 92,320,660.64 |
| 长期应付职工薪酬 | 2,439,564.4 | 2,393,224.4 | 2,346,201.38 | 2,366,461.79 |
| 递延收益 | 11,380,861.15 | 11,504,423.13 | 11,620,784.16 | 11,737,145.19 |
| 递延所得税负债 | 61,417,244.74 | 62,248,317.73 | 64,465,018.13 | 59,044,891.75 |
| 非流动负债合计 | 184,189,505.34 | 183,970,451.16 | 157,100,031.19 | 165,469,159.37 |
| 负债合计 | 799,413,480.27 | 850,462,901.49 | 860,399,830.63 | 893,929,604.27 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 223,086,347 | 223,086,347 | 223,086,347 | 223,086,347 |
| 资本公积 | 65,534,113.77 | 65,534,113.77 | 65,534,113.77 | 65,534,113.77 |
| 其他综合收益 | 181,103,486.57 | 184,019,218.36 | 187,967,979.89 | 172,017,631.73 |
| 盈余公积 | 105,358,170.09 | 105,358,170.09 | 97,704,403.34 | 97,704,403.34 |
| 未分配利润 | 606,550,402.66 | 583,287,816.88 | 586,464,182.08 | 547,218,488.39 |
| 归属于母公司股东权益合计 | 1,181,632,520.09 | 1,161,285,666.1 | 1,160,757,026.08 | 1,105,560,984.23 |
| 少数股东权益 | 9,973,936.01 | 9,575,745.28 | 9,537,136.3 | 9,084,308.49 |
| 股东权益合计 | 1,191,606,456.1 | 1,170,861,411.38 | 1,170,294,162.38 | 1,114,645,292.72 |
| 负债和股东权益合计 | 1,991,019,936.37 | 2,021,324,312.87 | 2,030,693,993.01 | 2,008,574,896.99 |
| 公告日期 | 2026-04-30 | 2026-04-09 | 2025-10-31 | 2025-08-20 |
| 审计意见(境内) | | 标准无保留意见 | | |